2nd Quarter - Report
DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Client
Income
—
Expenses
$87,644
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 22, 2019 | $87,644 | Replaced |
| 2nd Quarter - Amendment | Aug 19, 2020 | $87,644 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
overdose issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL COLLINS | — |
| GRANT SMITH | — |
Budget/Appropriations BUD
overdose, drug policy and criminal justice funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL COLLINS | — |
| MICHAEL LISZEWSKI New | — |
Law Enforcement/Crime/Criminal Justice LAW
criminal justice reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| QUEEN ABIMBOLA ADESUYI | — |
| MICHAEL COLLINS | — |
| GRANT SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.